Anti-Human CD20 Recombinant Antibody(Ocaratuzumab)

Name: Anti-Human CD20 Recombinant Antibody(Ocaratuzumab)
Brand: KMD Bioscience
SKU: YR1285

YR1285

科研级 Ocaratuzumab ( 奥卡妥珠单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab

DATASHEET MSDS

Product Description

Alias	科研级 Ocaratuzumab ( 奥卡妥珠单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab
Catalog Number	YR1285
Molecular Name	Ocaratuzumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity FcγRIIIa allotypes.
CAS Number	1169956-08-4
Application	Neut, ELISA, IF, IP, FuncS, FCM, ICC
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD20[Homo sapiens]

Login